Dexamethasone Administered Via the Epidural Catheter as an Adjunct in Patients Undergoing Cesarean Delivery
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the ability of dexamethasone to enhance labor epidurals when
administered as an adjunct to local anesthetics via an epidural catheter. Patients undergoing
elective cesarean sections will be randomized into three groups, each receiving the same
combined spinal epidural (CSE). At surgical closure, Group 1 will receive 10cc bupivacaine
0.0625%, Group 2 will receive 10cc bupivacaine 0.0625% +4mg dexamethasone, and Group 3 will
receive 10cc bupivacaine 0.0625% + 8mg dexamethasone (4mg). VAS, sedation, nausea, and
satisfaction scoring will be measured on patient follow-up to compare the outcomes of the
different treatment groups.